16
In August 2023, a breakthrough was made in the development of a new gene therapy vector AAV capsid! A team from the University of Pennsylvania has designed an AAV capsid that can efficiently target the central nervous system, providing a safer and more effective delivery tool for gene therapy of neurological diseases. The research findings were published in the journal Nature.
Latest News
